Lisa regularly analyzes federal and state statutes and regulations in connection with the federal Anti-Kickback Statute and Stark Law, New Jersey’s Codey Law and other state-specific self-referral laws, the federal False Claims Act, the New Jersey False Claims Act, Board of Medical Examiners regulations, licensing and reimbursement issues, and other fraud and abuse laws. Her clients include health care professionals as well as group practices and other health care entities, such as hospitals, academic medical centers, ambulatory surgery centers, management service organizations, ambulatory care facilities, substance use treatment facilities, mental health facilities (outpatient and inpatient), and nursing homes, among others.

Lisa’s health care, psychedelic, and cannabis clients rely on Lisa for regulatory advice and to guide them through transactional matters concerning mergers and acquisitions as well as the formation and structure of such entities, including joint ventures, affiliation agreements, and management services arrangements. Further, Lisa frequently lectures on ownership in health care practices and cannabis entities (buying in and separating from) and the related considerations and challenges.

On the forefront of the burgeoning cannabis industry and with many years of industry experience, Lisa helps clients in the cannabis space navigate the industry’s complicated and ever-changing regulatory landscape. Her cannabis law practice includes the representation of alternative treatment centers within the medicinal cannabis industry as well as start-ups and multistate operators in the personal adult-use cannabis industry, such as cultivators, manufacturers, retailers, delivery services, distributors, and testing laboratories. Lisa advises clients in connection with licensing, ownership, and regulatory compliance pursuant to state laws, rules, and regulations. Lisa also advises clients on regulatory considerations associated with anticipated mergers and acquisitions. Additionally, she provides advice to physicians, hospitals, and others doing business in the legal cannabis market in New Jersey concerning issues related to recommending, authorizing, administering, and possessing medical cannabis.